Tatyana Novoyatleva
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Death-associated protein kinase 1 prevents hypoxia-induced metabolic shift and pulmonary arterial smooth muscle cell proliferation in PAH.
Journal: Cellular signalling
Published: March 22, 2024
C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension.
Journal: Communications biology
Published: July 27, 2023
Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches.
Journal: International journal of molecular sciences
Published: May 03, 2023
Retraction: Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis.
Journal: American journal of respiratory cell and molecular biology
Published: September 01, 2022
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension.
Journal: BMC pulmonary medicine
Published: July 20, 2022
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: April 08, 2022
Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
Journal: Communications biology
Published: January 21, 2022
Adenylate Kinase 4-A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways.
Journal: International journal of molecular sciences
Published: September 07, 2021
Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.
Journal: International journal of environmental research and public health
Published: September 02, 2021
Genetic Delivery and Gene Therapy in Pulmonary Hypertension.
Journal: International journal of molecular sciences
Published: December 28, 2020
Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
Journal: International journal of molecular sciences
Published: December 22, 2020
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
Journal: Communications biology
Published: August 26, 2020
Last Updated: 09/26/2026